Barclays analyst Tim Long raised the firm’s price target on Axon to $247 from $239 and keeps an Overweight rating on the shares. The company reported another strong quarter with revenue, margins, adjusted EBITDA and earnings all ahead of estimates, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AXON:
